➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Johnson and Johnson
Moodys
McKinsey

Last Updated: October 20, 2021

DrugPatentWatch Database Preview

NOXAFIL POWDERMIX KIT Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Noxafil Powdermix Kit patents expire, and when can generic versions of Noxafil Powdermix Kit launch?

Noxafil Powdermix Kit is a drug marketed by Msd Merck Co and is included in one NDA.

The generic ingredient in NOXAFIL POWDERMIX KIT is posaconazole. There are twenty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the posaconazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Noxafil Powdermix Kit

A generic version of NOXAFIL POWDERMIX KIT was approved as posaconazole by SINOTHERAPEUTICS INC on August 21st, 2019.

  Free Forever Trial

Summary for NOXAFIL POWDERMIX KIT
Drug patent expirations by year for NOXAFIL POWDERMIX KIT
Pharmacology for NOXAFIL POWDERMIX KIT

US Patents and Regulatory Information for NOXAFIL POWDERMIX KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Msd Merck Co NOXAFIL POWDERMIX KIT posaconazole FOR SUSPENSION, DELAYED RELEASE;ORAL 214770-001 May 31, 2021 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Johnson and Johnson
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.